RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
  • Home
  • Impact
  • Publications
  • Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib

Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib

Li, B., Shin, H., Glubekyan, G., Pustovalova, O., Nikolsky, Y., Hope, A., Bessarabova, M., & Schu, M. (2015). Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib. PLoS One.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

"Show Me the Energy Costs"
Article

Food, energy, and water nexus research in Guatemala – A systematic literature review
Article

Urinary cadmium and stroke - a case-cohort study in Danish never-smokers
Article

Integrated energy-water-land nexus planning in the Colorado River Basin (Argentina)